Table 1.
Participant characteristics
| Baseline characteristic (N = 262) | Baseline | ||
|---|---|---|---|
| N (%) | M (SD) | Range | |
| Average age (years) | 53.8 (8.4) | 28.0–66.0 | |
| African American | 18 (6.9) | ||
| Body mass index | 40.4 (8.8) | 24.8–86.9 | |
| Female | 175 (66.8) | ||
| Years since type 2 diabetes diagnosis | 8.4 (7.2) | 0.0–33.0 | |
| Depressive disorder documented in external chart | 51 (19.5) | ||
| Meets clinical cut-off for depression | 36 (15.1) | ||
| Antidepressant prescribed | 99 (37.8) | ||
| Beta-hydroxybutyrate (mmol·L−1) | 0.17 (0.15) | 0.04–1.07 | |
| Insulin prescribed | 78 (29.8) | ||
| Insulin dosage (among those prescribed) | 90.6 (69.2) | 5.0–405.0 | |
| Number of diabetes-specific medications prescribed | 1.7 (1.1) | 0.0–5.0 | |
| White blood cells (k/cumm) | 7.2 (1.9) | 3.4–14.7 | |
| C-reactive protein (nmol L−1) | 7.6 (6.71) | 3.5–13.3 | |
M mean, SD standard deviation